Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin

NCT02235233 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of North Carolina, Chapel Hill

Collaborators